Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
MJFF Publications
Donate Now
Access Resources

MJFF Publications
3631 - 3640 of 8620 Results
Title
Year
  • Year
  • 2016
  • 2019
  • 2019
  • 2023
  • 2019
  • 2022
  • 2014
  • 2023
  • 2023
  • 2019
  • The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action
    2016
    Summary Details
    RESTRICTED
    Title: The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action
    Author(s): Dilan Athauda, Thomas Foltynie
    Journal Name: Drug Discovery Today
    Publisher: Elsevier BV
    Vol: 21
    Issue #: 5
    Start Page: 802
    End Page: 818
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.drudis.2016.01.013
    Best OA location URL: https://doi.org/10.1016/j.drudis.2016.01.013
    Citation Count: 246
  • Targeting the Dopaminergic System in Autoimmunity
    2019
    Summary Details
    RESTRICTED
    Title: Targeting the Dopaminergic System in Autoimmunity
    Author(s): Pía M. Vidal, Rodrigo Pacheco
    Journal Name: Journal of Neuroimmune Pharmacology
    Publisher: Springer Science and Business Media LLC
    Vol: 15
    Issue #: 1
    Start Page: 57
    End Page: 73
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s11481-019-09834-5
    Best OA location URL:
    Citation Count: 53
  • Diagnostic biomarkers for Parkinson's disease: focus on α-synuclein in cerebrospinal fluid
    2019
    Summary Details
    RESTRICTED
    Title: Diagnostic biomarkers for Parkinson's disease: focus on α-synuclein in cerebrospinal fluid
    Author(s): Lorraine V. Kalia
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 59
    Issue #:
    Start Page: 21
    End Page: 25
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.11.016
    Best OA location URL:
    Citation Count: 16
  • Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?
    2023
    Summary Details
    RESTRICTED
    Title: Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?
    Author(s): Viviana Brembati, Gaia Faustini, Francesca Longhena, Arianna Bellucci
    Journal Name: Frontiers in Molecular Neuroscience
    Publisher: Frontiers Media SA
    Vol: 16
    Issue #:
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnmol.2023.1197853
    Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2023.1197853/pdf
    Citation Count: 5
  • Small Molecules to Improve ER Proteostasis in Disease
    2019
    Summary Details
    RESTRICTED
    Title: Small Molecules to Improve ER Proteostasis in Disease
    Author(s): Vicente Gonzalez‐Teuber, Héctor Albert‐Gascó, Vincent C. Auyeung, Feroz R. Papa, Giovanna R. Mallucci, Claudio Hetz
    Journal Name: Trends in Pharmacological Sciences
    Publisher: Elsevier BV
    Vol: 40
    Issue #: 9
    Start Page: 684
    End Page: 695
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: publisher-specific-oa, publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.tips.2019.07.003
    Best OA location URL: http://manuscript.elsevier.com/S0165614719301403/pdf/S0165614719301403.pdf
    Citation Count: 63
  • Clinical neurophysiology of Parkinson’s disease and parkinsonism
    2022
    Summary Details
    RESTRICTED
    Title: Clinical neurophysiology of Parkinson’s disease and parkinsonism
    Author(s): Robert Chen, Alfredo Berardelli, Amitabh Bhattacharya, Matteo Bologna, Kai‐Hsiang Stanley Chen, Alfonso Fasano, Rick C. Helmich, William D. Hutchison, Nitish Kamble, Andrea A. Kühn, Antonella Macerollo, Wolf‐Julian Neumann, Pramod Kumar Pal, Giulia Paparella, Antonio Suppa, Kaviraja Udupa
    Journal Name: Clinical Neurophysiology Practice
    Publisher: Elsevier BV
    Vol: 7
    Issue #:
    Start Page: 201
    End Page: 227
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.cnp.2022.06.002
    Best OA location URL: https://doi.org/10.1016/j.cnp.2022.06.002
    Citation Count: 33
  • Accelerating Drug Development for the Field: Building Clinical Trial Recruitment Infrastructure in Parkinson’s
    2014
    Summary Details
    RESTRICTED
    Title: Accelerating Drug Development for the Field: Building Clinical Trial Recruitment Infrastructure in Parkinson’s
    Author(s): Claire C. Meunier, Sohini Chowdhury, Lily Cappelletti, Todd Sherer
    Journal Name:
    Publisher:
    Vol:
    Issue #:
    Start Page: 22
    End Page: 27
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.14524/cr-13-00066r1.1
    Best OA location URL:
    Citation Count: 1
  • Addition to “Nanostars Carrying Multifunctional Neurotrophic Dendrimers Protect Neurons in Preclinical In Vitro Models of Neurodegenerative Disorders”
    2023
    Summary Details
    RESTRICTED
    Title: Addition to “Nanostars Carrying Multifunctional Neurotrophic Dendrimers Protect Neurons in Preclinical In Vitro Models of Neurodegenerative Disorders”
    Author(s): Corinne Morfill, Stanislava Pankratova, Pedro Machado, Nathalie K. Fernando, Anna Regoutz, Federica Talamona, Alessandra Pinna, Michał M. Kłosowski, Robert J. Wilkinson, Roland A. Fleck, Fei Xie, Alexandra E. Porter, Darya Kiryushko
    Journal Name: ACS Applied Materials & Interfaces
    Publisher: American Chemical Society (ACS)
    Vol: 15
    Issue #: 10
    Start Page: 13824
    End Page: 13824
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1021/acsami.3c02300
    Best OA location URL: https://doi.org/10.1021/acsami.3c02300
    Citation Count: 0
  • Novel therapeutic approaches to target neurodegeneration
    2023
    Summary Details
    RESTRICTED
    Title: Novel therapeutic approaches to target neurodegeneration
    Author(s): Alerie Guzman de la Fuente, Silvia Pelucchi, Jérôme Mertens, Mónica Di Luca, Daniela Mauceri, Elena Marcello
    Journal Name: British Journal of Pharmacology
    Publisher: Wiley
    Vol: 180
    Issue #: 13
    Start Page: 1651
    End Page: 1673
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/bph.16078
    Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.16078
    Citation Count: 7
  • Huntington disease: A quarter century of progress since the gene discovery
    2019
    Summary Details
    RESTRICTED
    Title: Huntington disease: A quarter century of progress since the gene discovery
    Author(s): Claudia Testa, Joseph Jankovic
    Journal Name: Journal of the Neurological Sciences
    Publisher: Elsevier BV
    Vol: 396
    Issue #:
    Start Page: 52
    End Page: 68
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jns.2018.09.022
    Best OA location URL:
    Citation Count: 59
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.